JUPITER NEUROSCIENCES, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $46.75K.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2025-12-31 was $0.00.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $66.00K.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, issued for services for fiscal 2025 was $66.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | |
| 2026-03-31 | $46.75K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $66.00K 10-K · filed 2026-04-01 |
| 2025-06-30 | $66.00K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |